Mechanistic Investigation of Lysine-Targeted Covalent Inhibition of PI3Kδ via ONIOM QM:QM Computations

Volkan Fındık1,2, Betül Tuba Varınca Gerçik2, Öykü Sinek2

  • 1LPCT, UMR 7019, University of Lorraine, CNRS, 54000, Nancy, France.

Insights

Targeted covalent inhibitors targeting lysine residues in Phosphoinositide 3-kinase delta (PI3Kδ) show promise for cancer treatment. Quantum chemical calculations reveal the reaction mechanism, aiding in optimizing inhibitor efficiency for drug discovery.

Area of Science:

  • Biochemistry and Medicinal Chemistry
  • Computational Chemistry and Molecular Modeling

Background:

  • Phosphoinositide 3-kinase (PI3K) enzymes are critical drug targets, particularly in oncology, with inhibitors in clinical trials for various cancers.
  • Targeted covalent inhibitors offer advantages in drug discovery, and targeting lysine residues presents a novel strategy over traditional cysteine targeting.
  • Recent development of selective covalent PI3Kδ inhibitors targeting Lys779 with activated ester warheads necessitates understanding their reaction mechanism.

Purpose of the Study:

  • To elucidate the atomistic details of the covalent inhibition mechanism of PI3Kδ by ester inhibitors targeting Lys779.
  • To investigate the role of active site aspartate residues (Asp782 and Asp911) in modulating the reaction pathway.
  • To correlate computational findings with experimental kinetic data for optimizing inhibitor design.

Main Methods:

  • Quantum chemical calculations using the ONIOM M06-2X/6-31+G(d,p):PM6 method were performed on a PI3Kδ active site cluster model.
  • Analysis of Gibbs free energy profiles for alternative mechanistic pathways involving aminolysis reaction between Lys779 and various phenolic ester inhibitors.
  • Comparison of calculated energy barriers with experimentally determined inactivation (k_inact/K_I) values.

Main Results:

  • Calculations distinguished between noncovalent methyl ester and covalent activated phenolic ester inhibitors.
  • The reaction mechanism and preferred pathway (via Asp782 or Asp911) are dependent on the electronic nature (electron-withdrawing/donating) of the phenolate leaving group.
  • A clear correlation was observed between the calculated Gibbs free energy barriers and experimental kinetic data for differently substituted phenolic esters.

Conclusions:

  • The study provides detailed microscopic insights into the covalent inhibition mechanism of PI3Kδ by activated ester inhibitors.
  • The findings highlight the crucial role of the leaving group's electronic properties and active site aspartates in determining the reaction pathway.
  • This mechanistic understanding can guide the rational design and optimization of more efficient PI3Kδ inhibitors for therapeutic applications.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.9K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
7.0K
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.7K
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
837